4.3 Article

Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Memantine induces reversible neurologic impairment in patients with MS

P. Villoslada et al.

NEUROLOGY (2009)

Article Clinical Neurology

Effects of rivastigmine on memory and cognition in multiple sclerosis

Vahid Shaygannejad et al.

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2008)

Article Clinical Neurology

Predicting neuropsychological abnormalities in multiple sclerosis

Ralph H. B. Benedict et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)

Article Clinical Neurology

Effects of donepezil on memory and cognition in multiple sclerosis

Christopher Christodoulou et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)

Review Biotechnology & Applied Microbiology

Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond

SA Lipton

NATURE REVIEWS DRUG DISCOVERY (2006)

Article Geriatrics & Gerontology

Caregiver-administered neuropsychiatric inventory (CGA-NPI)

SJ Kang et al.

JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2004)

Article Medicine, General & Internal

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil - A randomized controlled trial

PN Tariot et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)

Article Medicine, General & Internal

Memantine in moderate-to-severe Alzheimer's disease

B Reisberg et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

Article Psychology, Clinical

Minimal neuropsychological assessment of MS patients: A consensus approach

RHB Benedict et al.

CLINICAL NEUROPSYCHOLOGIST (2002)